NCI | Technology Transfer

Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta

Read more about Methods to Prevent Tumor Recurrence by Blockade of TGF-Beta

Hong Kong
05111097.4
Filed on 2005-12-06

Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo

Read more about Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo

US Application 10/660,369
Filed on 2003-09-11

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 08/223,842
Filed on 1994-04-06

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Patent 5,494,807
Filed on 1993-08-12

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/897,382
Filed on 1992-06-11

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/847,951
Filed on 1992-03-06

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/715,921
Filed on 1991-06-14

NYVAC vaccinia virus recombinants comprising heterologous insects

Read more about NYVAC vaccinia virus recombinants comprising heterologous insects

US Application 07/713,967
Filed on 1991-06-11

A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding

Read more about A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding

Patent Cooperation Treaty
PCT/US2005/047431
Filed on 2005-12-30

Acridone-Derived Compounds Useful as Antineoplastic and Antiretroviral Agents

Read more about Acridone-Derived Compounds Useful as Antineoplastic and Antiretroviral Agents

Canada
2525550
Filed on 1997-04-09

Subscribe to NCI